Clinical trial
An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With Targin® in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)
NCT01811186 is registered in ClinicalTrials.gov with Mundipharma Korea Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With Targin® in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)
- Lead sponsor
- Mundipharma Korea Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- June 30, 2014
- Enrollment
- 261 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.